Jingjing Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jingjing Zhou has a total of 167 co-authors. Here are the top co-authors by number of shared publications:
- Gang Wang
Beijing Key Laboratory of Intelligent Drug Research and Development for Mental Disorders; National Clinical Research Center for Mental Disorders, National Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, China
10 shared publications Jing Liu
Beijing Anding Hospital, Capital Medical University
6 shared publicationsRuinan Li
Beijing Anding Hospital, Capital Medical University
6 shared publicationsXueshan Zhang
Beijing Anding Hospital, Capital Medical University
6 shared publicationsDan Li
Beijing Key Laboratory of Intelligent Drug Research and Development for Mental Disorders; National Clinical Research Center for Mental Disorders; National Center for Mental Disorders; Beijing Anding Hospital, Capital Medical University, Beijing, China
5 shared publicationsXiaoya Li
Beijing Anding Hospital, Capital Medical University
4 shared publications
Latest Publications
- Open Access
- 19 October 2026
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 56, e341
Stability of depressive and manic symptoms as a predictor of conversion from major depressive disorder to bipolar disorder: A prospective cohort study
Background: Bipolar disorder (BD) is characterized by mood fluctuations and is prone to misdiagnosis as major depressive disorder (MDD). Quantifying the relationship between symptom fluctuations and conversion risk is essential for early identification. Methods: In a national prospective cohort of patients with MDD (enrolled from May 2022 to February 2025), depressive and manic symptoms were assessed using clinician-rated and self-report instruments. Two measures were calculated: the time in target range (TTR), the proportion of numbers of evaluations with scores below predefined clinical cutoffs; and Statistical Process Control (SPC) stability, evaluated with a person-specific approach defining each individual’s normal fluctuation range via their 25th–75th percentiles. The outcome was the incidence of manic or hypomanic episodes that met the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition criteria. Cox regression models were used to evaluate the associations of the TTR and SPC with the conversion to BD. Results: Among the 2,367 eligible patients with MDD (mean [SD] age, 29.88 [9.79] years; 792 [33.46%] male), 69 (2.92%) converted to BD in the 52-week follow-up. During weeks 0-8, higher TTR of the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR16) (cutoff set at ≤10) and the 33-item Hypomania Checklist (HCL-33) (cutoffs set at ≤7 and ≤15) were significantly associated with a lower risk of conversion between Weeks 8 and 52. Additionally, a greater SPC-evaluated stability of the HCL-33 scores was significantly associated with lower conversion risk over the same period. Conclusions: While further validation in independent samples is still needed, continuous monitoring of hypomanic symptoms, especially evaluated with the HCL-33, may be of clinical significance for the early identification of conversion to BD.
- 19 October 2026
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 56, e341
Open AccessStability of depressive and manic symptoms as a predictor of conversion from major depressive disorder to bipolar disorder: A prospective cohort study
Background: Bipolar disorder (BD) is characterized by mood fluctuations and is prone to misdiagnosis as major depressive disorder (MDD). Quantifying the relationship between symptom fluctuations and conversion risk is essential for early identification. Methods: In a national prospective cohort of patients with MDD (enrolled from May 2022 to February 2025), depressive and manic symptoms were assessed using clinician-rated and self-report instruments. Two measures were calculated: the time in target range (TTR), the proportion of numbers of evaluations with scores below predefined clinical cutoffs; and Statistical Process Control (SPC) stability, evaluated with a person-specific approach defining each individual’s normal fluctuation range via their 25th–75th percentiles. The outcome was the incidence of manic or hypomanic episodes that met the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition criteria. Cox regression models were used to evaluate the associations of the TTR and SPC with the conversion to BD. Results: Among the 2,367 eligible patients with MDD (mean [SD] age, 29.88 [9.79] years; 792 [33.46%] male), 69 (2.92%) converted to BD in the 52-week follow-up. During weeks 0-8, higher TTR of the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR16) (cutoff set at ≤10) and the 33-item Hypomania Checklist (HCL-33) (cutoffs set at ≤7 and ≤15) were significantly associated with a lower risk of conversion between Weeks 8 and 52. Additionally, a greater SPC-evaluated stability of the HCL-33 scores was significantly associated with lower conversion risk over the same period. Conclusions: While further validation in independent samples is still needed, continuous monitoring of hypomanic symptoms, especially evaluated with the HCL-33, may be of clinical significance for the early identification of conversion to BD.
- Open Access
- 14 August 2026
- Published by Springer Nature in BMC Psychiatry
- Vol. 26 (1)
Temporal interference stimulation for working memory deficits in schizophrenia: a pilot trial
- 14 August 2026
- Published by Springer Nature in BMC Psychiatry
- Vol. 26 (1)
Open AccessTemporal interference stimulation for working memory deficits in schizophrenia: a pilot trial
- Open Access
- 4 August 2026
- Published by Springer Nature in Translational Psychiatry
- Vol. 16 (1)
Functional connectivity of anterior cingulate cortex subregions in suicidal ideation in major depression: circuit mechanisms, exploratory classification, and treatment-related changes
Suicidal ideation (SI) is a critical challenge in major depressive disorder (MDD), yet its precise neural circuitry remains elusive. Although anterior cingulate cortex (ACC) is implicated, its subregional roles remain poorly understood. This study aimed to delineate SI-specific neural circuitry by examining whole-brain functional connectivity (FC) of ACC subregions: subgenual ACC (sgACC), pregenual ACC (pgACC), and dorsal ACC (dACC). Resting-state functional magnetic resonance imaging data were analyzed from 237 MDD patients (109 with SI [MDD-SI], 128 without SI [MDD-NSI]) and 152 healthy controls (HCs) at baseline. Group assignment relied on lifetime SI (trait-like SI) from the Columbia-Suicide Severity Rating Scale, with current SI (state-like SI) measured by the suicide item of 17-item Hamilton Depression Rating Scale. Of these, 129 MDD patients underwent 8-week follow-up scanning after treatment. Cross-sectional analysis identified two SI-specific FC alterations: left pgACC-right precuneus and left dACC-left fusiform connectivity. These FCs were enhanced in MDD-SI compared to MDD-NSI, showed no differences between MDD-NSI and HCs, and correlated with trait-like SI severity. An exploratory model incorporating these FCs and clinical covariates achieved an area under the curve (AUC) of 0.723 for trait-like SI identification. Longitudinally, the baseline elevation in left pgACC-right precuneus FC normalized after treatment specifically in MDD-SI, and this reduction paralleled the decrease in state-like SI severity. Our findings clarify ACC subregion-specific SI mechanisms, provide an exploratory evaluation of trait-like SI identification and identify a potential state-like SI therapeutic circuit. Collectively, this work translates vague ACC abnormality into localizable circuits, advancing precision neuroscience for MDD-SI.
- 4 August 2026
- Published by Springer Nature in Translational Psychiatry
- Vol. 16 (1)
Open AccessFunctional connectivity of anterior cingulate cortex subregions in suicidal ideation in major depression: circuit mechanisms, exploratory classification, and treatment-related changes
Suicidal ideation (SI) is a critical challenge in major depressive disorder (MDD), yet its precise neural circuitry remains elusive. Although anterior cingulate cortex (ACC) is implicated, its subregional roles remain poorly understood. This study aimed to delineate SI-specific neural circuitry by examining whole-brain functional connectivity (FC) of ACC subregions: subgenual ACC (sgACC), pregenual ACC (pgACC), and dorsal ACC (dACC). Resting-state functional magnetic resonance imaging data were analyzed from 237 MDD patients (109 with SI [MDD-SI], 128 without SI [MDD-NSI]) and 152 healthy controls (HCs) at baseline. Group assignment relied on lifetime SI (trait-like SI) from the Columbia-Suicide Severity Rating Scale, with current SI (state-like SI) measured by the suicide item of 17-item Hamilton Depression Rating Scale. Of these, 129 MDD patients underwent 8-week follow-up scanning after treatment. Cross-sectional analysis identified two SI-specific FC alterations: left pgACC-right precuneus and left dACC-left fusiform connectivity. These FCs were enhanced in MDD-SI compared to MDD-NSI, showed no differences between MDD-NSI and HCs, and correlated with trait-like SI severity. An exploratory model incorporating these FCs and clinical covariates achieved an area under the curve (AUC) of 0.723 for trait-like SI identification. Longitudinally, the baseline elevation in left pgACC-right precuneus FC normalized after treatment specifically in MDD-SI, and this reduction paralleled the decrease in state-like SI severity. Our findings clarify ACC subregion-specific SI mechanisms, provide an exploratory evaluation of trait-like SI identification and identify a potential state-like SI therapeutic circuit. Collectively, this work translates vague ACC abnormality into localizable circuits, advancing precision neuroscience for MDD-SI.
- 22 July 2026
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (12) , 7264-7273
Efficacy and safety of adjunctive transcranial alternating current stimulation in bipolar depression: A randomized controlled trial
- 22 July 2026
- Published by Springer Nature in Molecular Psychiatry
- Vol. 31 (12) , 7264-7273
Efficacy and safety of adjunctive transcranial alternating current stimulation in bipolar depression: A randomized controlled trial
- Top Cited PapersOpen Access
- 17 June 2026
- Published by Elsevier in Cell Host & Microbe
- Vol. 34 (7) , 1367-1382.e7
Adjunctive fecal microbiota transplantation for major depressive disorder: A randomized, double-blind, placebo-controlled trial
- 17 June 2026
- Published by Elsevier in Cell Host & Microbe
- Vol. 34 (7) , 1367-1382.e7
Top Cited PapersOpen AccessAdjunctive fecal microbiota transplantation for major depressive disorder: A randomized, double-blind, placebo-controlled trial
- 24 April 2026
- Published by Elsevier in Journal of Affective Disorders
- Vol. 408, 121857
High-intensity transcranial alternating current stimulation enhances functional connectivity of subcortical regions in major depressive disorder
- 24 April 2026
- Published by Elsevier in Journal of Affective Disorders
- Vol. 408, 121857
High-intensity transcranial alternating current stimulation enhances functional connectivity of subcortical regions in major depressive disorder
- 12 February 2026
- Published by Elsevier in Journal of Affective Disorders
- Vol. 402, 121392
Differential effects of individualized vs. fixed-frequency tACS on clinical and EEG outcomes in major depressive disorder
- 12 February 2026
- Published by Elsevier in Journal of Affective Disorders
- Vol. 402, 121392
Differential effects of individualized vs. fixed-frequency tACS on clinical and EEG outcomes in major depressive disorder
- Open Access
- 1 January 2026
- Published by Wiley in Depression and Anxiety
- Vol. 2026 (1) , 4701907
Distinct Trajectories of Amygdala Connectivity Patterns Characterize Remission vs. Non‐Remission in Patients With Major Depressive Disorder
Background: This study aimed to investigate the neural basis of individual differences in antidepressant efficacy using an 8‐week longitudinal multitime point resting‐state functional magnetic resonance imaging (fMRI) design. Methods: Forty‐eight patients with major depressive disorder (MDD) completed two or three scans, and 44 healthy controls (HCs) underwent a baseline scan. Patients were categorized into remission (MDDr) and nonremission (MDDnr) groups based on treatment outcomes. Group differences in resting‐state functional connectivity (rsFC) of the amygdala subregions at baseline were examined among MDDr, MDDnr, and HCs. Longitudinal changes in the identified rsFC were compared between the MDDr and MDDnr groups. Correlation analyses were conducted to explore the relationship between baseline rsFC or its longitudinal changes and depressive symptom severity or improvement. Results: At baseline, rsFC between the right basolateral (BL) amygdala and the right supplementary motor area (SMA) was lower in the MDDr group but higher in the MDDnr group compared with HCs, although this effect did not survive multiple comparisons correction across amygdala subregions. The trajectory of this rsFC differed between the two patient groups during treatment, with normalization observed at 2 and 8 weeks posttreatment. Correlation analyses indicated that baseline rsFC was associated with treatment response and that longitudinal changes in rsFC were aligned with symptom improvement, although some associations did not survive multiple comparisons correction. Conclusions: Our findings provide novel and valuable insights into the neural mechanisms underlying antidepressant response and highlight the role of amygdala subregional connectivity in explaining interindividual variability in treatment efficacy. Trial Registration: ClinicalTrials.gov identifier: ChiCTR2400093823
- 1 January 2026
- Published by Wiley in Depression and Anxiety
- Vol. 2026 (1) , 4701907
Open AccessDistinct Trajectories of Amygdala Connectivity Patterns Characterize Remission vs. Non‐Remission in Patients With Major Depressive Disorder
Background: This study aimed to investigate the neural basis of individual differences in antidepressant efficacy using an 8‐week longitudinal multitime point resting‐state functional magnetic resonance imaging (fMRI) design. Methods: Forty‐eight patients with major depressive disorder (MDD) completed two or three scans, and 44 healthy controls (HCs) underwent a baseline scan. Patients were categorized into remission (MDDr) and nonremission (MDDnr) groups based on treatment outcomes. Group differences in resting‐state functional connectivity (rsFC) of the amygdala subregions at baseline were examined among MDDr, MDDnr, and HCs. Longitudinal changes in the identified rsFC were compared between the MDDr and MDDnr groups. Correlation analyses were conducted to explore the relationship between baseline rsFC or its longitudinal changes and depressive symptom severity or improvement. Results: At baseline, rsFC between the right basolateral (BL) amygdala and the right supplementary motor area (SMA) was lower in the MDDr group but higher in the MDDnr group compared with HCs, although this effect did not survive multiple comparisons correction across amygdala subregions. The trajectory of this rsFC differed between the two patient groups during treatment, with normalization observed at 2 and 8 weeks posttreatment. Correlation analyses indicated that baseline rsFC was associated with treatment response and that longitudinal changes in rsFC were aligned with symptom improvement, although some associations did not survive multiple comparisons correction. Conclusions: Our findings provide novel and valuable insights into the neural mechanisms underlying antidepressant response and highlight the role of amygdala subregional connectivity in explaining interindividual variability in treatment efficacy. Trial Registration: ClinicalTrials.gov identifier: ChiCTR2400093823
- Open Access
- 1 January 2025
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- p. 1-26
Group-Based Trajectory Analysis of Depressive Symptoms in Patients Treated with Antidepressants in Chinese Cohort Studies
The Brazilian Journal of Psychiatry is the official publication of Brazilian Psychiatric Association (Associação Brasileira de Psiquiatria - ABP)
- 1 January 2025
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- p. 1-26
Open AccessGroup-Based Trajectory Analysis of Depressive Symptoms in Patients Treated with Antidepressants in Chinese Cohort Studies
The Brazilian Journal of Psychiatry is the official publication of Brazilian Psychiatric Association (Associação Brasileira de Psiquiatria - ABP)
- Open Access
- 1 January 2025
- Published by Wiley in Depression and Anxiety
- Vol. 2025 (1)
Interrelationships Among Personality Traits, Depressive Symptoms, Childhood Abuse, and Social Disability
Background: Personality traits and childhood abuse were found to be associated with depressive symptoms and with each other. However, no previous study has elucidated the directional interrelationship among those factors in a clinical population of patients with major depressive disorder (MDD). This study sought to construct networks to explicate the directional interrelationship among those factors and social disability, identify the most central factor, and explore potentially existing causality chains implied by the directed association chains. Methods: This cross‐sectional study analyzed data from 1445 patients with MDD in a national cohort. Personality traits were measured using the Eysenck Personality Questionnaire‐Revised Short Scale for Chinese (EPQ‐RSC). Seven dimensions of depressive symptoms were measured with various scales: depression, anxiety, insomnia, and somatic symptoms with the 17‐item Hamilton Depression Rating Scale (HAMD‐17), the loss of pleasure sensation with the Snaith‐Hamilton Pleasure Scale (SHAPS), apathy with the Modified Apathy Evaluation Scale (MAES), and fatigue with the Chalder Fatigue Scale (CFS‐11). Childhood abuse experience was measured using the Childhood Trauma Questionnaire‐Short Form (CTQ‐SF). Social disability was measured with the Sheehan Disability Scale (SDS). Undirected and Bayesian network analyses were used to identify central factors and explore directional interrelationships among the variables. Results: The loss of pleasure sensation was the most central in terms of strength and closeness. In the directed acyclic graph (DAG) derived from the Bayesian network analysis, psychoticism was positioned at the highest level in the model, suggesting its causal precedence. One key directed association chain, which implied a potentially existing causality chain, was that psychoticism predicted the loss of pleasure sensation, and this symptom predicted social disability. Conclusion: Loss of pleasure sensation and psychoticism might be important for future research in MDD. The appearance of psychoticism at the beginning of the directed association chain (which implied a potentially existing causality chain) involving the central factor and the characteristics of high psychoticism implied that the social/interpersonal component of the loss of pleasure sensation may be a meaningful focus of future research and intervention of MDD. Trial Registration: Chinese Clinical Trial Registry: ChiCTR2200059053
- 1 January 2025
- Published by Wiley in Depression and Anxiety
- Vol. 2025 (1)
Open AccessInterrelationships Among Personality Traits, Depressive Symptoms, Childhood Abuse, and Social Disability
Background: Personality traits and childhood abuse were found to be associated with depressive symptoms and with each other. However, no previous study has elucidated the directional interrelationship among those factors in a clinical population of patients with major depressive disorder (MDD). This study sought to construct networks to explicate the directional interrelationship among those factors and social disability, identify the most central factor, and explore potentially existing causality chains implied by the directed association chains. Methods: This cross‐sectional study analyzed data from 1445 patients with MDD in a national cohort. Personality traits were measured using the Eysenck Personality Questionnaire‐Revised Short Scale for Chinese (EPQ‐RSC). Seven dimensions of depressive symptoms were measured with various scales: depression, anxiety, insomnia, and somatic symptoms with the 17‐item Hamilton Depression Rating Scale (HAMD‐17), the loss of pleasure sensation with the Snaith‐Hamilton Pleasure Scale (SHAPS), apathy with the Modified Apathy Evaluation Scale (MAES), and fatigue with the Chalder Fatigue Scale (CFS‐11). Childhood abuse experience was measured using the Childhood Trauma Questionnaire‐Short Form (CTQ‐SF). Social disability was measured with the Sheehan Disability Scale (SDS). Undirected and Bayesian network analyses were used to identify central factors and explore directional interrelationships among the variables. Results: The loss of pleasure sensation was the most central in terms of strength and closeness. In the directed acyclic graph (DAG) derived from the Bayesian network analysis, psychoticism was positioned at the highest level in the model, suggesting its causal precedence. One key directed association chain, which implied a potentially existing causality chain, was that psychoticism predicted the loss of pleasure sensation, and this symptom predicted social disability. Conclusion: Loss of pleasure sensation and psychoticism might be important for future research in MDD. The appearance of psychoticism at the beginning of the directed association chain (which implied a potentially existing causality chain) involving the central factor and the characteristics of high psychoticism implied that the social/interpersonal component of the loss of pleasure sensation may be a meaningful focus of future research and intervention of MDD. Trial Registration: Chinese Clinical Trial Registry: ChiCTR2200059053